Amanote Research
Register
Sign In
Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery
doi 10.1021/acsmedchemlett.7b00414.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Dual Anti‐vascular Function of Human Fibulin‐3 Variant, a Potential New Drug Discovery Strategy for Glioblastoma
Cancer Science
Cancer Research
Medicine
Oncology
New and Emerging HDAC Inhibitors for Cancer Treatment
Journal of Clinical Investigation
Medicine
Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer
Oncotarget
Oncology
Discovery of Novel NAMPT Inhibitors Based on Pharmacophore Modeling and Virtual Screening Techniques
Combinatorial Chemistry and High Throughput Screening
Medicine
Organic Chemistry
Drug Discovery
Computer Science Applications
Discovery of New Thiophene, Pyrazole, Isoxazole Derivatives as Antitumor, C-Met, Tyrosine Kinase and Pim-1 Kinase Inhibitors
Bulletin of the Chemical Society of Ethiopia
Chemistry
Metabolic Clustering Analysis as a Strategy for Compound Selection in the Drug Discovery Pipeline for Leishmaniasis
Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel in Vitro and in Vivo
PLoS ONE
Multidisciplinary
PubChem as a Public Resource for Drug Discovery
Drug Discovery Today
Drug Discovery
Pharmacology
Yeast as a Model System for Drug Discovery
Folia Pharmacologica Japonica
Pharmacology
